You are here

HKEX

RemeGen readies $514M IPO as HKEX adds jewel to the crown

Endpoints

Wed, 10/28/20 - 10:43 am

Ophthalmic drugs, cancer cell therapies attract $340M+ on two HKEX biotech debuts

Endpoints

Fri, 07/10/20 - 10:52 am

Ocumension Therapeutics

Immunotech Biopharm

Tasly Biopharma pitches long-awaited IPO — will it trigger another $1B gold rush on HKEX?

Endpoints

Tue, 06/25/19 - 11:28 pm

Tasly Biopharma